Chargement en cours...
Expected population impacts of discontinued prostate-specific antigen screening
BACKGROUND: Prostate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagnosis, particularly in older men, and reports from screening trials indicate that it saves few lives after 11–13 years of follow-up. New clinical guidelines recommend against PSA screening for all men...
Enregistré dans:
| Publié dans: | Cancer |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221407/ https://ncbi.nlm.nih.gov/pubmed/25065910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28932 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|